Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.

Market Dynamics

Key companies in the market are focusing on product launches and approvals for meningitis vaccines which is expected to boost the global meningitis vaccines market growth over the forecast period. For instance, in June 2021, CanSinoBIO, an innovative biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has a trade name: Menphecia. Menphecia delivers protection against infection of Group A and C Neisseria meningitides.

Moreover, in May 2019, the Ministry of Health of Ireland had approved the menACWY vaccine to be administered to thousands of children & adults in Ireland due to rising cases of meningitis that were reported in 2018.

Key features of the study:

This report provides in-depth analysis of the global meningitis vaccines market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Novartis AG, Walvax Biotechnology Co., Ltd., Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Vacsera, Zhi Fei Biological, BIO MED, Chengdu Kanghua Biological Products, Bharat Biotech., LG Chem, Espromed Bio, Panacea Biotec Limited, Sinovac Biotech Co., Ltd., CanSinoBIO, and Eubiologics Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningitis vaccines market

Detailed Segmentation:

Global Meningitis Vaccines Market, By Vaccine:
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
- Meningococcal Vaccine
- Others
Global Meningitis Vaccines Market, By Age Group:
- Infants
- Adults
Global Meningitis Vaccines Market, By Distribution Channel:
- Government
- Private
Global Meningitis Vaccines Market, By Country:
- Egypt
- Nigeria
- Morocco
- Indonesia
- Bangladesh
- Malaysia
- United Arab Emirates
- Saudi Arabia
- Pakistan
- Turkey
- Kazakhstan
- Jordan
- Qatar
- Sudan
- Lebanon
- Uganda
- Benin
- Cameroon
- Gabon
- Cote d'Ivoire
- Vietnam
- Singapore
- Mexico
- Argentina
- Thailand
- Philippines
- Nepal
- Myanmar
- Rest of the World
Company Profiles
- GlaxoSmithKline plc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi S.A.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Walvax Biotechnology Co., Ltd.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd.
- Vacsera
- Zhi Fei Biological
- BIO MED
- Chengdu Kanghua Biological Products
- Bharat Biotech.
- LG Chem
- Espromed Bio
- Panacea Biotec Limited
- Sinovac Biotech Co., Ltd.
- CanSinoBIO
- Eubiologics Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5042

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Age Group
- Market Snapshots, By Distribution Channel
- Market Snapshot, By Country
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
PEST Analysis
Epidemiology
Vaccine Development Cycle
Vaccine Types/Technology and Route of Administration
Pricing Analysis
Pipeline Analysis
Brand Comparison Mapping

4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Meningitis Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pneumococcal Conjugate Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pneumococcal Polysaccharide Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Meningococcal Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Meningitis Vaccines Market, By Age Group, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Infants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Meningitis Vaccines Market, By Country, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Countries, 2018-2030
- Country Trends
Egypt
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Nigeria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Morocco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Indonesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Bangladesh
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Malaysia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
United Arab Emirates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Saudi Arabia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Pakistan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Kazakhstan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Jordan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Qatar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Sudan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Lebanon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Uganda
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Benin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Cameroon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Gabon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Cote d'Ivoire
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Vietnam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Singapore
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Thailand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Philippines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Nepal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Myanmar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of the World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)

9. Competitive Landscape

GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Walvax Biotechnology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Incepta Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vacsera
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhi Fei Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BIO MED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chengdu Kanghua Biological Products
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bharat Biotech.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LG Chem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Espromed Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Panacea Biotec Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sinovac Biotech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CanSinoBIO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eubiologics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030